Zobrazeno 1 - 10
of 335
pro vyhledávání: '"Mariella E"'
Publikováno v:
Neotropical Entomology; Apr2024, Vol. 53 Issue 2, p323-329, 7p
Autor:
Pessei V; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Macagno M; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Mariella E; Department of Oncology, University of Torino, Turin, Italy.; IFOM, the AIRC Institute of Molecular Oncology, Milan, Italy., Congiusta N; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Battaglieri V; Department of Oncology, University of Torino, Turin, Italy.; IFOM, the AIRC Institute of Molecular Oncology, Milan, Italy., Battuello P; Department of Oncology, University of Torino, Turin, Italy.; IFOM, the AIRC Institute of Molecular Oncology, Milan, Italy., Viviani M; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Gionfriddo G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Lamba S; Department of Oncology, University of Torino, Turin, Italy., Lorenzato A; Department of Oncology, University of Torino, Turin, Italy., Oddo D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Idrees F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Cavaliere A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Bartolini A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Guarrera S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; IIGM-Italian Institute for Genomic Medicine, c/o IRCCS, Candiolo, Turin, Italy., Linnebacher M; Clinic of General Surgery, Molecular Oncology and Immunotherapy, UMR, Rostock, Germany., Monteonofrio L; Department of Research and Advanced Technologies, Regina Elena National Cancer Institute IRCCS, Rome, Italy., Cardone L; Department of Research and Advanced Technologies, Regina Elena National Cancer Institute IRCCS, Rome, Italy., Milella M; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and Verona University and Hospital Trust, Verona, Italy., Bertotti A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Soddu S; Department of Research and Advanced Technologies, Regina Elena National Cancer Institute IRCCS, Rome, Italy., Grassi E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Crisafulli G; IFOM, the AIRC Institute of Molecular Oncology, Milan, Italy., Bardelli A; Department of Oncology, University of Torino, Turin, Italy.; IFOM, the AIRC Institute of Molecular Oncology, Milan, Italy., Barault L; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. ludovic.barault@gmail.com.; Department of Oncology, University of Torino, Turin, Italy. ludovic.barault@gmail.com., Di Nicolantonio F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. federica.dinicolantonio@unito.it.; Department of Oncology, University of Torino, Turin, Italy. federica.dinicolantonio@unito.it.
Publikováno v:
Genome medicine [Genome Med] 2024 Oct 09; Vol. 16 (1), pp. 118. Date of Electronic Publication: 2024 Oct 09.
Autor:
Russo M; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy. mariangela.russo@unito.it.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy. mariangela.russo@unito.it., Chen M; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mariella E; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy., Peng H; Institute of Thoracic Oncology and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Rehman SK; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Sogari A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy., Toh TS; Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Balaban NQ; Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem, Israel., Batlle E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Garnett MJ; Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Hangauer M; Department of Dermatology, University of California San Diego, San Diego, CA, USA., Leucci E; Department of Oncology, KU Leuven, Leuven, Belgium., Marine JC; Department of Oncology, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., O'Brien CA; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Oren Y; Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Patton EE; MRC Human Genetics Unit, and CRUK Scotland Centre and Edinburgh Cancer Research, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK., Robert C; Oncology Department, Dermatology Unit, Villejuif, France.; Oncology Department and INSERM U981, Villejuif, France.; Paris Saclay University, Villejuif, France., Rosenberg SM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Shen S; Institute of Thoracic Oncology and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China., Bardelli A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy. alberto.bardelli@unito.it.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy. alberto.bardelli@unito.it.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2024 Oct; Vol. 24 (10), pp. 694-717. Date of Electronic Publication: 2024 Sep 02.
Autor:
Mariella E; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Grasso G; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Miotto M; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Buzo K; Department of Oncology, University of Torino, Candiolo (TO), Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy., Reilly NM; Department of Oncology, University of Torino, Candiolo (TO), Italy., Andrei P; Department of Oncology, University of Torino, Candiolo (TO), Italy., Vitiello PP; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Crisafulli G; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Arena S; Department of Oncology, University of Torino, Candiolo (TO), Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy., Rospo G; Department of Oncology, University of Torino, Candiolo (TO), Italy., Corti G; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy., Lorenzato A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy., Cancelliere C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy., Barault L; Department of Oncology, University of Torino, Candiolo (TO), Italy., Gionfriddo G; Department of Oncology, University of Torino, Candiolo (TO), Italy., Linnebacher M; Clinic of General Surgery, Molecular Oncology and Immunotherapy, University of Rostock, Germany., Russo M; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Di Nicolantonio F; Department of Oncology, University of Torino, Candiolo (TO), Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy., Bardelli A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Jun; Vol. 18 (6), pp. 1460-1485. Date of Electronic Publication: 2024 Mar 11.
Autor:
Amy L. Robinson, Helen Williamson, Mariella E. Güere, Helene Tharaldsen, Karis Baker, Stephanie L. Smith, Sílvia Pérez-Espona, Jarmila Krojerová-Prokešová, Josephine M. Pemberton, Wilfred Goldmann, Fiona Houston
Publikováno v:
Veterinary Research, Vol 50, Iss 1, Pp 1-10 (2019)
Abstract Susceptibility to prion diseases is largely determined by the sequence of the prion protein gene (PRNP), which encodes the prion protein (PrP). The recent emergence of chronic wasting disease (CWD) in Europe has highlighted the need to inves
Externí odkaz:
https://doaj.org/article/c55d70b18c544a28b2c22cb17a46c220
Autor:
Sogari A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy., Rovera E; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy., Grasso G; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy., Mariella E; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy., Reilly NM; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy., Lamba S; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy., Mauri G; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Durinikova E; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy., Vitiello PP; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy., Lorenzato A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy., Avolio M; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy., Piumatti E; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy., Bonoldi E; Department of Pathology, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Aquilano MC; Department of Pathology, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Arena S; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Torino, 10060 Candiolo, Italy., Sartore-Bianchi A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Division of Clinical Research and Innovation, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Siena S; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Trusolino L; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Torino, 10060 Candiolo, Italy., Donalisio M; Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy., Russo M; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy., Di Nicolantonio F; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Torino, 10060 Candiolo, Italy., Lembo D; Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy., Bardelli A; Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy. Electronic address: alberto.bardelli@unito.it.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Feb 20; Vol. 5 (2), pp. 101376. Date of Electronic Publication: 2024 Jan 15.
Autor:
Mauri G; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy gianluca.mauri@unimi.it.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Patelli G; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Roazzi L; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Valtorta E; Department of Pathology, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Amatu A; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Marrapese G; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bonazzina E; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Tosi F; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bencardino K; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Ciarlo G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Mariella E; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology, Molecular Biotechnology Center, University of Torino, Turin, Italy., Marsoni S; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy., Bardelli A; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology, Molecular Biotechnology Center, University of Torino, Turin, Italy., Bonoldi E; Department of Pathology, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Division of Research and Innovation, Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Siena S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Publikováno v:
Journal of clinical pathology [J Clin Pathol] 2024 Feb 13. Date of Electronic Publication: 2024 Feb 13.
Evolution of Silk Anchor Structure as the Joint Effect of Spinning Behavior and Spinneret Morphology
Autor:
Peter Michalik, Mariella E Herberstein, Martín J. Ramírez, Jonas O. Wolff, Alexandra M. Ravelo
Publikováno v:
Integrative and Comparative Biology. 61:1411-1431
Synopsis Spider web anchors are attachment structures composed of the bi-phasic glue-fiber secretion from the piriform silk glands. The mechanical performance of the anchors strongly correlates with the structural assembly of the silk lines, which ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b774844aa6ba76433bf08683050b26af
https://doi.org/10.1093/icb/icab003
https://doi.org/10.1093/icb/icab003
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.